Skip to main content

CITADEL ADVISORS LLC

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1423053 MIAMI, FL

Position in KNSA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,664,476
-$20,194,736 QoQ
Shares Held
41,665
-91.2% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Derivatives in KNSA

reported options exposure · as of Jun 30, 2026
CallValue
$901,695
CallShares
14,100
PutValue
$364,515
PutShares
5,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,121,114 across 64 Drug Manufacturers - Specialty & Generic names. KNSA ranks #24 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KNSA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,664,476 41,665
2026-06-30 $364,515 5,700
2026-06-30 $901,695 14,100
2026-03-31 $22,859,212 474,750
2026-03-31 $630,765 13,100
2026-03-31 $568,170 11,800
2025-12-31 $30,612,366 742,118
2025-12-31 $499,125 12,100
2025-09-30 $12,214,209 314,556
2025-09-30 $318,406 8,200
2025-09-30 $547,503 14,100
2025-06-30 $890,974 32,200
2025-06-30 $7,398,763 267,393
2025-03-31 $124,376 5,600
2025-03-31 $268,741 12,100
2025-03-31 $1,346,969 60,647
2024-12-31 $6,024,512 304,576
2024-12-31 $81,098 4,100
2024-12-31 $104,834 5,300
2024-09-30 $242,403 9,700
2024-09-30 $4,958,340 198,413
2024-09-30 $159,936 6,400
2024-06-30 $147,493 7,900
2024-06-30 $1,023,488 54,820
2024-06-30 $16,803 900